Harnessing the Synergy of SGLT2 Inhibitors and Continuous Ketone Monitoring (CKM) in Managing Heart Failure among Patients with Type 1 Diabetes

Harnessing the Synergy of SGLT2 Inhibitors and Continuous Ketone Monitoring (CKM) in Managing Heart Failure among Patients with Type 1 Diabetes

Heart failure (HF) management in type 1 diabetes (T1D) is particularly challenging due to its increased prevalence and the associated risks of hospitalization and mortality, driven by diabetic cardiomyopathy. Sodium–glucose cotransporter-2 inhibitors (SGLT2-is) offer a promising avenue for treating...

Full description

Bibliographic Details
Main Authors: Nicola Tecce, Giorgio de Alteriis, Giulia de Alteriis, Ludovica Verde, Mario Felice Tecce, Annamaria Colao, Giovanna Muscogiuri
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Healthcare
Subjects:
heart failure
type 1 diabetes
diabetic cardiomyopathy
hospitalization
HFpEF
HFrEF
Online Access:https://www.mdpi.com/2227-9032/12/7/753

Internet

https://www.mdpi.com/2227-9032/12/7/753

Similar Items